Concentra’s Strategic Acquisition of Nova Medical Centers Enhances Service Offerings and Financial Outlook, Leading to Buy Recommendation
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CON stock, giving a Buy rating yesterday.Invest with Confidence: ...
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is ...